2021 Investor Day

Financial Strategy | Key takeaways O2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 1 Building on our strong track record of revenue growth with compelling future opportunities driven by accelerating adoption of digital health technologies for sleep apnea and COPD 2 Growing our portfolio of value-adding businesses and expanding recurring revenue in large markets 3 Driving operating margin expansion through revenue growth and SG&A leverage, while continuing to invest in R&D 4 Leveraging our strong cash flow and balance sheet for both organic and inorganic investments with a focus on driving long-term stakeholder value 88

View entire presentation